Syndax Pharmaceuticals, Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $1.3 Billion | 10/19 | KRTX $12.6B |
PCVX $10.6B |
RVMD $7.6B |
CYTK $5.0B |
MRUS $2.8B |
EWTX $2.4B |
DICE $2.3B |
DYN $1.4B |
VRDN $1.4B |
SNDX $1.3B |
REPL $1.0B |
COGT $899.2M |
KROS $413.2M |
LRMR $206.1M |
PLRX $165.5M |
STRO $132.8M |
INZY $86.7M |
MRSN $80.3M |
AVTE $70.7M |
Gross Margin | 100% | 1/19 | SNDX 100% |
CYTK 100% |
MRSN 100% |
MRUS 100% |
STRO 100% |
KROS 100% |
VRDN 100% |
DYN 0% |
COGT 0% |
KRTX 0% |
REPL 0% |
RVMD 0% |
LRMR 0% |
PLRX 0% |
PCVX 0% |
INZY 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
Profit Margin | -100% | 14/19 | DYN 0% |
COGT 0% |
KRTX 0% |
REPL 0% |
RVMD 0% |
LRMR 0% |
PLRX 0% |
PCVX 0% |
INZY 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
MRSN -91% |
SNDX -100% |
CYTK -100% |
MRUS -100% |
STRO -100% |
KROS -100% |
VRDN -100% |
EBITDA margin | -717% | 14/19 | MRSN -77% |
DYN -100% |
COGT -100% |
KRTX -100% |
REPL -100% |
RVMD -100% |
LRMR -100% |
PLRX -100% |
PCVX -100% |
INZY -100% |
EWTX -100% |
AVTE -100% |
DICE -100% |
SNDX -717% |
STRO -797% |
MRUS -823% |
KROS -15118% |
CYTK -29859% |
VRDN -97070% |
Quarterly Revenue | $12.5 Million | 2/19 | MRSN $12.6M |
SNDX $12.5M |
MRUS $11.8M |
STRO $8.5M |
CYTK $463,000 |
KROS $388,000 |
VRDN $86,000 |
DYN $0 |
COGT $0 |
KRTX $0 |
REPL $0 |
RVMD $0 |
LRMR $0 |
PLRX $0 |
PCVX $0 |
INZY $0 |
EWTX $0 |
AVTE $0 |
DICE $0 |
Quarterly Earnings | -$84.1 Million | 13/19 | MRSN -$11.5M |
LRMR -$15.5M |
AVTE -$16.2M |
INZY -$24.6M |
EWTX -$34.1M |
DICE -$34.8M |
STRO -$48.8M |
KROS -$53.0M |
REPL -$53.1M |
PLRX -$57.8M |
COGT -$70.6M |
VRDN -$76.7M |
SNDX -$84.1M |
DYN -$97.1M |
MRUS -$99.9M |
PCVX -$103.1M |
KRTX -$113.8M |
RVMD -$156.3M |
CYTK -$160.5M |
Quarterly Free Cash Flow | -$62.3 Million | 12/19 | MRSN -$8.6M |
AVTE -$16.0M |
PCVX -$21.7M |
INZY -$24.5M |
LRMR -$24.6M |
EWTX -$27.9M |
DICE -$30.4M |
KROS -$30.9M |
PLRX -$33.2M |
REPL -$40.7M |
COGT -$52.3M |
SNDX -$62.3M |
STRO -$65.3M |
VRDN -$68.0M |
DYN -$74.9M |
MRUS -$80.7M |
CYTK -$104.0M |
KRTX -$111.9M |
RVMD -$133.9M |
Trailing 4 Quarters Revenue | $16.5 Million | 4/19 | STRO $161.0M |
MRUS $35.9M |
MRSN $34.8M |
SNDX $16.5M |
PLRX $4.8M |
DYN $3.8M |
CYTK $3.2M |
KRTX $654,000 |
KROS $651,000 |
VRDN $302,000 |
COGT $0 |
REPL $0 |
RVMD $0 |
LRMR $0 |
PCVX $0 |
INZY $0 |
EWTX $0 |
AVTE $0 |
DICE $0 |
Trailing 4 Quarters Earnings | -$302.0 Million | 15/19 | MRSN $12.6M |
SNDX $12.5M |
MRUS $11.8M |
STRO $8.5M |
CYTK $463,000 |
KROS $388,000 |
VRDN $86,000 |
DYN -$0 |
COGT -$0 |
KRTX -$0 |
REPL -$0 |
RVMD -$0 |
LRMR -$0 |
PLRX -$0 |
PCVX -$0 |
INZY -$0 |
EWTX -$0 |
AVTE -$0 |
DICE -$0 |
Quarterly Earnings Growth | -64% | 17/19 | MRSN 72% |
AVTE 17% |
REPL 12% |
RVMD 9% |
STRO 1% |
PCVX -11% |
CYTK -24% |
COGT -28% |
EWTX -33% |
KROS -34% |
PLRX -39% |
INZY -48% |
KRTX -49% |
DYN -61% |
VRDN -61% |
DICE -62% |
SNDX -64% |
LRMR -71% |
MRUS -334% |
Annual Earnings Growth | -63% | 16/19 | MRSN 64% |
STRO 25% |
REPL -2% |
AVTE -10% |
CYTK -12% |
DYN -16% |
RVMD -16% |
KROS -19% |
VRDN -21% |
DICE -26% |
PLRX -28% |
COGT -29% |
KRTX -37% |
EWTX -38% |
INZY -52% |
SNDX -63% |
PCVX -71% |
LRMR -90% |
MRUS -105% |
Quarterly Revenue Growth | 0% | 6/19 | KROS 4750% |
MRSN 64% |
CYTK 22% |
VRDN 19% |
MRUS 7% |
SNDX 0% |
DYN 0% |
COGT 0% |
REPL 0% |
LRMR 0% |
PLRX 0% |
PCVX 0% |
INZY 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
STRO -50% |
KRTX -100% |
RVMD -100% |
Annual Revenue Growth | 0% | 6/19 | KROS 8038% |
PLRX 551% |
STRO 234% |
CYTK 8% |
VRDN 5% |
SNDX 0% |
DYN 0% |
COGT 0% |
REPL 0% |
LRMR 0% |
PCVX 0% |
INZY 0% |
EWTX 0% |
AVTE 0% |
DICE 0% |
MRSN -12% |
MRUS -15% |
KRTX -88% |
RVMD -100% |
Cash On Hand | $133.0 Million | 9/19 | PCVX $1.1B |
DYN $532.2M |
KROS $530.7M |
MRUS $433.0M |
RVMD $201.3M |
VRDN $200.3M |
KRTX $185.8M |
STRO $174.6M |
SNDX $133.0M |
REPL $113.5M |
COGT $97.0M |
PLRX $79.6M |
MRSN $78.9M |
DICE $73.5M |
CYTK $46.9M |
EWTX $44.8M |
LRMR $35.1M |
AVTE $31.1M |
INZY $24.6M |
Short Term Debt | $852,000 | 16/19 | CYTK $30.4M |
MRSN $19.0M |
PCVX $9.6M |
RVMD $8.4M |
STRO $7.2M |
DYN $4.8M |
INZY $4.6M |
REPL $4.0M |
KRTX $2.8M |
KROS $1.9M |
MRUS $1.8M |
DICE $1.5M |
COGT $1.5M |
LRMR $1.0M |
EWTX $992,000 |
SNDX $852,000 |
AVTE $459,000 |
PLRX $322,000 |
VRDN -$0 |
Long Term Debt | $0 | 18/19 | CYTK $759.3M |
RVMD $78.3M |
REPL $72.2M |
PLRX $59.9M |
INZY $42.2M |
VRDN $20.5M |
DYN $20.0M |
MRSN $18.6M |
PCVX $18.3M |
STRO $17.7M |
KROS $17.4M |
COGT $16.3M |
KRTX $13.8M |
DICE $11.0M |
LRMR $4.3M |
EWTX $3.4M |
AVTE $81,000 |
SNDX $0 |
MRUS $0 |
PE | -1.00 | 1/19 | SNDX -1.00 |
DYN -1.00 |
COGT -1.00 |
CYTK -1.00 |
MRSN -1.00 |
MRUS -1.00 |
KRTX -1.00 |
REPL -1.00 |
STRO -1.00 |
RVMD -1.00 |
KROS -1.00 |
LRMR -1.00 |
PLRX -1.00 |
PCVX -1.00 |
INZY -1.00 |
EWTX -1.00 |
VRDN -1.00 |
AVTE -1.00 |
DICE -1.00 |
PS | 76.71 | 6/19 | KRTX 19264.95 |
VRDN 4684.57 |
CYTK 1546.39 |
KROS 634.68 |
DYN 373.97 |
SNDX 76.71 |
MRUS 76.71 |
PLRX 34.20 |
MRSN 2.30 |
STRO 0.82 |
COGT -1.00 |
REPL -1.00 |
RVMD -1.00 |
LRMR -1.00 |
PCVX -1.00 |
INZY -1.00 |
EWTX -1.00 |
AVTE -1.00 |
DICE -1.00 |
PB | 3.46 | 7/19 | MRSN 76.55 |
KRTX 10.05 |
EWTX 5.01 |
RVMD 4.83 |
DICE 4.37 |
MRUS 3.92 |
SNDX 3.46 |
PCVX 3.12 |
COGT 2.86 |
REPL 2.72 |
DYN 2.01 |
VRDN 2.00 |
STRO 1.19 |
INZY 1.05 |
LRMR 1.04 |
AVTE 0.88 |
KROS 0.78 |
PLRX 0.48 |
CYTK 0.00 |
PC | 9.54 | 7/19 | CYTK 106.16 |
KRTX 67.80 |
EWTX 54.63 |
RVMD 37.56 |
DICE 30.91 |
PCVX 10.14 |
SNDX 9.54 |
COGT 9.27 |
REPL 9.15 |
VRDN 7.06 |
MRUS 6.37 |
LRMR 5.88 |
INZY 3.53 |
DYN 2.66 |
AVTE 2.27 |
PLRX 2.08 |
MRSN 1.02 |
KROS 0.78 |
STRO 0.76 |
Liabilities to Equity | 0.16 | 8/19 | MRSN 160.61 |
STRO 3.06 |
INZY 0.73 |
REPL 0.31 |
PLRX 0.29 |
COGT 0.22 |
MRUS 0.20 |
SNDX 0.16 |
RVMD 0.13 |
AVTE 0.13 |
LRMR 0.10 |
DYN 0.09 |
KROS 0.09 |
VRDN 0.09 |
KRTX 0.07 |
DICE 0.06 |
EWTX 0.05 |
PCVX 0.04 |
CYTK 0.00 |
ROA | -0.71 | 18/19 | PCVX -14% | DICE -18% | EWTX -24% | STRO -27% | MRUS -29% | LRMR -30% | RVMD -31% | KROS -31% | KRTX -32% | VRDN -33% | DYN -39% | CYTK -40% | MRSN -43% | REPL -43% | PLRX -47% | COGT -63% | INZY -67% | SNDX -71% | AVTE -93% |
ROE | -0.82 | 15/19 | CYTK 4143% |
PCVX -15% |
DICE -19% |
EWTX -25% |
LRMR -33% |
KRTX -34% |
RVMD -34% |
KROS -34% |
MRUS -35% |
VRDN -36% |
DYN -42% |
REPL -56% |
PLRX -61% |
COGT -77% |
SNDX -82% |
AVTE -105% |
STRO -111% |
INZY -117% |
MRSN -7020% |
Current Ratio | 7.17 | 11/19 | PCVX 25.05 |
EWTX 22.82 |
DICE 17.42 |
KRTX 16.30 |
KROS 12.47 |
DYN 12.15 |
VRDN 11.99 |
LRMR 10.62 |
RVMD 8.96 |
AVTE 8.69 |
SNDX 7.17 |
MRUS 5.97 |
COGT 5.54 |
PLRX 4.46 |
REPL 4.27 |
INZY 2.37 |
STRO 1.33 |
MRSN 1.01 |
CYTK 0.99 |
Quick Ratio | 6.56 | 11/19 | SNDX -1.00 |
DYN -1.00 |
COGT -1.00 |
CYTK -1.00 |
MRSN -1.00 |
MRUS -1.00 |
KRTX -1.00 |
REPL -1.00 |
STRO -1.00 |
RVMD -1.00 |
KROS -1.00 |
LRMR -1.00 |
PLRX -1.00 |
PCVX -1.00 |
INZY -1.00 |
EWTX -1.00 |
VRDN -1.00 |
AVTE -1.00 |
DICE -1.00 |
Long Term Debt to Equity | 0.00 | 16/19 | MRSN} 17.72 |
INZY} 0.51 |
REPL} 0.19 |
PLRX} 0.17 |
STRO} 0.16 |
COGT} 0.05 |
RVMD} 0.05 |
DYN} 0.03 |
KROS} 0.03 |
VRDN} 0.03 |
LRMR} 0.02 |
DICE} 0.02 |
KRTX} 0.01 |
PCVX} 0.01 |
EWTX} 0.01 |
SNDX} 0.00 |
MRUS} 0.00 |
AVTE} 0.00 |
CYTK} -54.58 |
Debt to Equity | 0.00 | 17/19 | MRSN 30.03 |
INZY 0.57 |
STRO 0.22 |
REPL 0.20 |
PLRX 0.17 |
COGT 0.06 |
RVMD 0.06 |
DYN 0.04 |
KROS 0.04 |
LRMR 0.03 |
VRDN 0.03 |
DICE 0.02 |
KRTX 0.01 |
PCVX 0.01 |
EWTX 0.01 |
AVTE 0.01 |
SNDX 0.00 |
MRUS 0.00 |
CYTK -48.51 |
Burn Rate | 1.58 | 13/19 | PCVX 9.88 |
KROS 9.81 |
DYN 5.37 |
MRSN 4.64 |
MRUS 4.32 |
STRO 3.40 |
VRDN 2.58 |
LRMR 2.20 |
DICE 2.06 |
REPL 1.99 |
AVTE 1.90 |
KRTX 1.61 |
SNDX 1.58 |
COGT 1.35 |
PLRX 1.32 |
EWTX 1.30 |
RVMD 1.25 |
INZY 0.90 |
CYTK 0.24 |
Cash to Cap | 0.10 | 13/19 | STRO 1.32 |
KROS 1.28 |
MRSN 0.98 |
PLRX 0.48 |
AVTE 0.44 |
DYN 0.38 |
INZY 0.28 |
LRMR 0.17 |
MRUS 0.16 |
VRDN 0.14 |
COGT 0.11 |
REPL 0.11 |
SNDX 0.10 |
PCVX 0.10 |
RVMD 0.03 |
DICE 0.03 |
EWTX 0.02 |
CYTK 0.01 |
KRTX 0.01 |
CCR | 0.74 | 14/19 | LRMR 1.59 |
STRO 1.34 |
INZY 1.00 |
AVTE 0.99 |
KRTX 0.98 |
VRDN 0.89 |
DICE 0.87 |
RVMD 0.86 |
EWTX 0.82 |
MRUS 0.81 |
DYN 0.77 |
REPL 0.77 |
MRSN 0.75 |
SNDX 0.74 |
COGT 0.74 |
CYTK 0.65 |
KROS 0.58 |
PLRX 0.57 |
PCVX 0.21 |
EV to EBITDA | -12.68 | 15/19 | KROS} 1.67 |
STRO} 0.25 |
COGT} -1.00 |
REPL} -1.00 |
RVMD} -1.00 |
LRMR} -1.00 |
PCVX} -1.00 |
INZY} -1.00 |
EWTX} -1.00 |
AVTE} -1.00 |
DICE} -1.00 |
PLRX} -2.36 |
MRSN} -3.40 |
DYN} -8.64 |
SNDX} -12.68 |
VRDN} -14.79 |
MRUS} -23.99 |
CYTK} -40.55 |
KRTX} -96.25 |
EV to Revenue | 68.71 | 5/19 | KRTX 19006.33 |
VRDN 4089.22 |
CYTK 1741.48 |
DYN 240.04 |
SNDX 68.71 |
MRUS 64.71 |
PLRX 30.19 |
MRSN 0.95 |
STRO -0.11 |
COGT -1.00 |
REPL -1.00 |
RVMD -1.00 |
LRMR -1.00 |
PCVX -1.00 |
INZY -1.00 |
EWTX -1.00 |
AVTE -1.00 |
DICE -1.00 |
KROS -150.88 |